Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Prod Res ; 35(4): 641-645, 2021 Feb.
Article in English | MEDLINE | ID: mdl-30887819

ABSTRACT

For the first time, the cytotoxic and phytochemical investigation of the leaves of Stereospermum binhchauensis V.S. Dang, a new species discovered in Viet Nam were finalized and led to purify nine compounds, including one furancoumarin (1), one chromone (3), two triterpenoids (2, 4), two flavonoids (5, 8), two flavanoids (6, 7) and one iridoid (9) using various chromatography methods. Their structures were verified by HR-ESI-MS, NMR experiments and compared with previous literatures. For the first time, compounds (5-8) were realized from the genus Stereospermum, while compounds (1, 2, 3, 4 & 9) were designated from the species S. binhchauensis. Furthermore, the furancoumarin, chromone and flavanoid classes were notified for the first time from the genus Stereospermum.


Subject(s)
Antineoplastic Agents/pharmacology , Bignoniaceae/chemistry , Phytochemicals/analysis , Phytochemicals/pharmacology , Plant Leaves/chemistry , Antineoplastic Agents/analysis , Cell Death/drug effects , Cell Line, Tumor , Humans , Phytochemicals/chemistry , Plant Extracts/chemistry
2.
Neurosci Lett ; 650: 38-44, 2017 05 22.
Article in English | MEDLINE | ID: mdl-28414132

ABSTRACT

Glucocorticoid receptor (GR) promoter I7 is susceptible to epigenetic changes induced by environmental influences. Early life stress (ELS) has a persistent impact on GR expression, as well as behavior, in adult rodents via epigenetic changes of GR promoter I7. Moreover, various stressors can induce histone modifications in this region during adulthood. Thus, the present study aimed to investigate whether maternally separated (MS) rats exposed to chronic restraint stress (RS) would exhibit histone modifications of GR promoter I7 in the hippocampus. Rats were subjected to MS (3h per day) on postnatal days (PND) 1-21. Then, during adulthood (PND 56-77), the rats were exposed to RS (2h per day) followed by treatment with escitalopram (10mg/kg). The MS and RS groups exhibited significant decreases in total and exon I7 GR mRNA levels and the combination of MS and RS exerted a greater effect on these mRNA levels than either MS or RS alone. Additionally, both the MS and RS groups showed significant reductions in histone H3 acetylation at GR promoter I7 and the combination of MS and RS had a greater effect than did either MS or RS alone. Chronic escitalopram treatment ameliorated these changes. The present results indicate that postnatal MS and adult RS influence GR expression through histone modification at GR promoter I7, and that the combination of the two stressors potentiates these changes. Furthermore, epigenetic mechanisms are involved in escitalopram action.


Subject(s)
Citalopram/therapeutic use , Epigenesis, Genetic/genetics , Maternal Deprivation , Promoter Regions, Genetic/genetics , Receptors, Glucocorticoid/genetics , Stress, Psychological/drug therapy , Stress, Psychological/physiopathology , Animals , Antidepressive Agents, Second-Generation/therapeutic use , Female , Gene Expression Regulation, Developmental/genetics , Histone Code/genetics , Male , Rats , Rats, Sprague-Dawley , Receptors, Glucocorticoid/metabolism
3.
Neuropharmacology ; 105: 388-397, 2016 06.
Article in English | MEDLINE | ID: mdl-26877199

ABSTRACT

Early life stress (ELS) exerts long-lasting epigenetic influences on the brain and makes an individual susceptible to later depression. It is poorly understood whether ELS and subsequent adult chronic stress modulate epigenetic mechanisms. We examined the epigenetic mechanisms of the BDNF gene in the hippocampus, which may underlie stress vulnerability to postnatal maternal separation (MS) and adult restraint stress (RS). Rat pups were separated from their dams (3 h/day from P1-P21). When the pups reached adulthood (8 weeks old), we introduced RS (2 h/day for 3 weeks) followed by escitalopram treatment. We showed that both the MS and RS groups expressed reduced levels of total and exon IV BDNF mRNA. Furthermore, RS potentiated MS-induced decreases in these expression levels. Similarly, both the MS and RS groups showed decreased levels of acetylated histone H3 and H4 at BDNF promoter IV, and RS exacerbated MS-induced decreases of H3 and H4 acetylation. Both the MS and RS groups had increased MeCP2 levels at BDNF promoter IV, as well as increased HDAC5 mRNA, and the combination of MS and RS exerted a greater effect on these parameters than did RS alone. In the forced swimming test, the immobility time of the MS + RS group was significantly higher than that of the RS group. Additionally, chronic escitalopram treatment recovered these alterations. Our results suggest that postnatal MS and subsequent adult RS modulate epigenetic changes in the BDNF gene, and that these changes may be related to behavioral phenotype. These epigenetic mechanisms are involved in escitalopram action.


Subject(s)
Brain-Derived Neurotrophic Factor/genetics , Epigenesis, Genetic/drug effects , Hippocampus/drug effects , Stress, Psychological/psychology , Adult , Animals , Antidepressive Agents, Second-Generation/therapeutic use , Anxiety, Separation , Citalopram/therapeutic use , Female , Hippocampus/metabolism , Histone Deacetylases/biosynthesis , Histone Deacetylases/genetics , Histones/metabolism , Humans , Male , Pregnancy , Rats, Sprague-Dawley , Restraint, Physical , Swimming/psychology
4.
J Affect Disord ; 196: 1-10, 2016 May 15.
Article in English | MEDLINE | ID: mdl-26896741

ABSTRACT

BACKGROUND: p11 (S100A10) is a key regulator of depression-like behaviors and antidepressant drug response in rodent models. Recent studies suggest that p11 mediates the behavioral antidepressant action of brain-derived neurotrophic factor (BDNF) in rodents. BDNF improves neural plasticity, which is linked to the cellular actions of antidepressant drugs. In the present study, we investigated whether p11 regulated BDNF action on neural plasticity in vitro. METHODS: We generated primary hippocampal cultures. p11 expression, total dendritic length, and spine density were investigated under toxic conditions induced by B27 deprivation, which causes hippocampal cell death. RESULTS: B27 deprivation significantly decreased p11 expression. Treatment with BDNF significantly prevented the B27 deprivation-induced decrease in p11 levels in a concentration-dependent manner, whereas these concentrations had no effect on control cultures. B27 deprivation significantly reduced the total length of hippocampal dendrites and spine density. BDNF increased the total dendritic length and spine density in conditions with or without B27. Furthermore, p11 knockdown through small interfering RNA (siRNA) transfection blocked these effects. The overexpression of p11 in B27-deprived cells increased the total dendritic length and spine density, and treatment with BDNF potentiated these effects. LIMITATION: This study should be confirmed in animal models of depression. CONCLUSION: Taken together, our data suggest that BDNF-induced improvement in neural plasticity may depend on the regulation of p11 in hippocampal cells with B27 deprivation. These results provide evidence to strengthen the theoretical basis of a role for p11 in BDNF-induced antidepressant action.


Subject(s)
Annexin A2/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Dendrites/genetics , Hippocampus/metabolism , S100 Proteins/metabolism , Animals , Antidepressive Agents/pharmacology , Depression/genetics , Hippocampus/drug effects , Mice , Neuronal Plasticity/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...